See more : Nissha Co., Ltd. (7915.T) Income Statement Analysis – Financial Results
Complete financial analysis of Poly Medicure Limited (POLYMED.NS) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Poly Medicure Limited, a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- eBASE Co.,Ltd. (3835.T) Income Statement Analysis – Financial Results
- Scorpio Tankers Inc. (STNG) Income Statement Analysis – Financial Results
- SSHT S&T Group Ltd. (SSHT) Income Statement Analysis – Financial Results
- New Zealand Rural Land Company Limited (NZL.NZ) Income Statement Analysis – Financial Results
- East China Engineering Science and Technology Co., Ltd. (002140.SZ) Income Statement Analysis – Financial Results
Poly Medicure Limited (POLYMED.NS)
About Poly Medicure Limited
Poly Medicure Limited manufactures and sells medical devices. It offers infusion devices, such as I.V. cannulas, mid line catheters, arterial cannula, three way stop cocks, I.V. infusion sets, manifolds, safety winged infusion sets, T-type extension sets, stylet/mandrin with luer locks, vial access spikes, measured volume fluid administration sets, extension lines, central venous catheters, CVP manometers, needle free connectors, pre filled syringes, vascular accesses, and blood administration sets. The company also provides nasogastric and infant feeding tubes, gastro-duodenal feeding tubes, and umbilical catheters; urine collection bags, foley balloon catheters, irrigation sets, urine drainage catheters, and urine collection bags with measured volume meters; and endotracheal tubes, tracheostomy tubes, mucus extractors, ventilator circuits, bain circuits, catheter mounts, spinal needles, HME filters, and laryngeal mask airways. In addition, it offers oncology products; endo bronchial suction catheters, oxygen catheters, respiratory exercisers, nasal oxygen cannulas, oro-pharyngeal airways, variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, and aerosol therapy masks; and dialyzers, blood lines, dialysis systems, fistula needles, haemodialysis catheters, and peritoneal dialysis and transfusion sets. Further, it provides closed wound suction units, under water seal drainage systems, high pressure vacuum bottles, yankauer suction sets, and thoracic drainage catheters; blood collection tubes, safety blood collection sets, blood collection needles, erythrocyte sedimentation rate pipettes, and luer adaptors; blood bag systems; face protective shields, polymasks, and viral transport medium kits; and insulin syringes, sputum collectors, dry brushes, umbilical cord clamps, luer locks, cannula fixators, injection stoppers, luer lock injection sites, and universal caps. The company was incorporated in 1995 and is based in New Delhi, India.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 13.76B | 11.15B | 9.17B | 7.75B | 6.69B | 5.91B | 5.07B | 4.48B | 4.07B | 3.84B | 3.15B | 2.55B | 2.17B | 1.73B | 1.37B | 1.12B | 883.82M | 848.97M |
Cost of Revenue | 4.87B | 4.06B | 4.33B | 3.36B | 2.86B | 2.72B | 2.26B | 2.02B | 1.86B | 1.81B | 1.39B | 1.13B | 755.97M | 900.55M | 701.61M | 590.85M | 526.66M | 502.42M |
Gross Profit | 8.89B | 7.09B | 4.84B | 4.39B | 3.84B | 3.19B | 2.81B | 2.46B | 2.21B | 2.03B | 1.75B | 1.42B | 1.41B | 828.96M | 670.30M | 531.39M | 357.16M | 346.55M |
Gross Profit Ratio | 64.62% | 63.61% | 52.75% | 56.59% | 57.32% | 53.96% | 55.46% | 54.99% | 54.37% | 52.86% | 55.69% | 55.68% | 65.17% | 47.93% | 48.86% | 47.35% | 40.41% | 40.82% |
Research & Development | 189.60M | 178.03M | 187.71M | 131.45M | 119.42M | 101.49M | 100.48M | 90.34M | 87.11M | 84.67M | 59.24M | 39.95M | 25.84M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 2.48B | 175.73M | 171.63M | 168.31M | 171.81M | 156.82M | 110.03M | 121.35M | 88.07M | 78.31M | 103.87M | 44.30M | 0.00 | 185.30M | 165.41M | 191.37M | 97.55M | 79.33M |
Selling & Marketing | 33.91M | 205.12M | 150.77M | 126.28M | 147.18M | 161.79M | 128.03M | 157.47M | 117.89M | 136.53M | 95.01M | 78.18M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 2.52B | 380.85M | 322.40M | 294.59M | 318.99M | 318.61M | 238.05M | 278.81M | 205.96M | 214.84M | 198.88M | 122.48M | 0.00 | 185.30M | 165.41M | 191.37M | 97.55M | 79.33M |
Other Expenses | 0.00 | 361.85M | 35.46M | 12.26M | 8.71M | 28.52M | 8.52M | 6.75M | 9.45M | 7.34M | 4.12M | 1.65M | 1.03B | 366.30M | 295.33M | 48.02M | 140.46M | 22.87M |
Operating Expenses | 2.71B | 5.01B | 3.20B | 2.68B | 2.57B | 2.22B | 1.88B | 1.75B | 1.54B | 1.36B | 1.09B | 858.50M | 1.06B | 551.60M | 460.75M | 419.41M | 238.01M | 220.06M |
Cost & Expenses | 7.57B | 9.07B | 7.53B | 6.05B | 5.42B | 4.94B | 4.14B | 3.77B | 3.40B | 3.17B | 2.49B | 1.99B | 1.81B | 1.45B | 1.16B | 1.01B | 764.67M | 722.47M |
Interest Income | 118.36M | 59.74M | 22.91M | 33.73M | 48.79M | 52.96M | 20.21M | 18.39M | 21.19M | 21.65M | 2.67M | 378.00K | 1.87M | 897.00K | 558.00K | 351.00K | 0.00 | 0.00 |
Interest Expense | 130.51M | 88.39M | 37.24M | 77.38M | 180.03M | 117.86M | 98.05M | 71.40M | 79.27M | 82.34M | 78.74M | 58.45M | 68.08M | 43.92M | 41.10M | 48.02M | 38.28M | 22.89M |
Depreciation & Amortization | 639.27M | 571.24M | 538.74M | 474.42M | 404.66M | 372.32M | 292.02M | 237.13M | 210.29M | 187.71M | 140.55M | 129.69M | 117.40M | 94.24M | 78.32M | 67.48M | 57.23M | 39.17M |
EBITDA | 4.19B | 3.01B | 2.52B | 2.33B | 1.76B | 1.51B | 1.37B | 1.07B | 857.76M | 1.12B | 751.79M | 518.42M | 454.62M | 372.26M | 287.96M | 177.60M | 175.81M | 165.64M |
EBITDA Ratio | 30.43% | 27.21% | 26.55% | 29.93% | 27.46% | 25.13% | 26.67% | 22.66% | 23.16% | 23.46% | 23.90% | 20.39% | 21.81% | 21.49% | 21.02% | 16.23% | 19.96% | 19.51% |
Operating Income | 6.19B | 2.09B | 1.60B | 1.67B | 1.24B | 936.95M | 933.23M | 624.57M | 588.94M | 787.97M | 631.49M | 330.51M | 288.38M | 238.65M | 175.45M | 111.98M | 119.15M | 126.50M |
Operating Income Ratio | 44.96% | 18.72% | 17.41% | 21.53% | 18.52% | 15.85% | 18.39% | 13.95% | 14.46% | 20.53% | 20.07% | 12.96% | 13.29% | 13.80% | 12.79% | 9.98% | 13.48% | 14.90% |
Total Other Income/Expenses | -2.74B | -2.43B | -1.91B | -1.85B | -13.65M | 32.28M | 34.29M | 127.32M | -1.07B | -812.76M | -191.17M | 0.00 | -101.61M | 0.00 | -5.95M | -45.94M | -38.85M | -23.48M |
Income Before Tax | 3.44B | 2.37B | 1.95B | 1.80B | 1.26B | 1.00B | 967.52M | 717.09M | 650.42M | 847.52M | 631.49M | 330.51M | 288.38M | 238.65M | 175.45M | 66.04M | 80.30M | 103.01M |
Income Before Tax Ratio | 25.02% | 21.30% | 21.29% | 23.23% | 18.79% | 16.93% | 19.07% | 16.02% | 15.97% | 22.08% | 20.07% | 12.96% | 13.29% | 13.80% | 12.79% | 5.88% | 9.09% | 12.13% |
Income Tax Expense | 860.09M | 582.09M | 487.39M | 441.80M | 298.45M | 346.76M | 261.58M | 199.77M | 175.69M | 230.99M | 191.19M | 97.76M | 96.27M | 22.50M | 18.03M | 7.19M | 4.07M | 20.31M |
Net Income | 2.58B | 1.79B | 1.47B | 1.36B | 958.78M | 653.99M | 705.94M | 523.19M | 482.68M | 623.23M | 450.94M | 242.30M | 194.69M | 216.72M | 157.99M | 59.62M | 76.95M | 82.71M |
Net Income Ratio | 18.77% | 16.08% | 15.98% | 17.53% | 14.33% | 11.07% | 13.91% | 11.69% | 11.85% | 16.24% | 14.33% | 9.50% | 8.97% | 12.53% | 11.52% | 5.31% | 8.71% | 9.74% |
EPS | 26.92 | 18.69 | 15.28 | 15.25 | 10.86 | 7.41 | 8.00 | 6.25 | 5.47 | 7.06 | 5.12 | 2.75 | 2.21 | 2.46 | 1.79 | 0.68 | 0.88 | 0.96 |
EPS Diluted | 26.90 | 18.67 | 15.27 | 15.24 | 10.86 | 7.41 | 8.00 | 6.25 | 5.47 | 7.06 | 5.11 | 2.75 | 2.21 | 2.46 | 1.79 | 0.68 | 0.83 | 0.95 |
Weighted Avg Shares Out | 95.95M | 95.92M | 95.89M | 89.08M | 88.25M | 88.24M | 88.23M | 88.23M | 88.23M | 88.19M | 88.12M | 88.10M | 88.10M | 88.10M | 88.10M | 88.10M | 87.12M | 86.40M |
Weighted Avg Shares Out (Dil) | 96.02M | 96.02M | 95.96M | 89.16M | 88.28M | 88.25M | 88.25M | 88.25M | 88.23M | 88.19M | 88.21M | 88.16M | 88.23M | 88.10M | 88.10M | 88.10M | 92.22M | 86.67M |
Source: https://incomestatements.info
Category: Stock Reports